Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
38.1 /100
Rank 15 out of 27 Sectors -
Advance/Decline
115/95
-
No. of Companies210
-
Avg. Market Cap9,626
-
Price to Earning Ratio32.14
-
Price to Earning Growth Ratio3.02
-
Price to Book Ratio6.09
-
Return on Equity36.41
-
Return on Capital Employed-
-
Return on Assets5.84
-
Dividend yield 1 year %0.26 %
-
Net Profit Growth Annual YoY %-4.37 %
-
Net Profit Growth Qtr YoY %13.34 %
-
Net Profit Growth Qtr QoQ %-1.09 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
37,927.8
|
134.3
|
L
 0.5%
H
132.5
136.3
|
L
 2.8%
H
127.5
136.3
|
L
 2.0%
H
123.7
138.6
|
L
 16.7%
H
108.4
141.1
|
L
 8.2%
H
108.4
160.3
|
L
 13.5%
H
96.4
160.3
|
L
 -10.5%
H
96.4
179.6
|
L
 195.3%
H
42.9
179.6
|
| Amerisource Bergen Corp |
|
-
|
303.4
|
L
 0.3%
H
300.8
304.8
|
L
 2.3%
H
292.5
310.5
|
L
 7.9%
H
269.3
310.5
|
L
 -5.4%
H
244.8
328.0
|
L
 2.1%
H
244.8
377.5
|
L
 57.4%
H
174.2
377.5
|
L
 163.6%
H
111.3
377.5
|
L
 270.4%
H
68.4
377.5
|
| Abbott |
|
163,608.5
|
93.9
|
L
 -0.5%
H
93.5
95.0
|
L
 -1.5%
H
93.0
98.1
|
L
 5.3%
H
87.1
98.1
|
L
 -6.4%
H
82.0
102.5
|
L
 -29.7%
H
82.0
137.5
|
L
 -12.2%
H
82.0
141.2
|
L
 -21.6%
H
82.0
142.6
|
L
 124.2%
H
37.4
142.6
|
| Alcon Inc - Registered Shares |
|
33,070.9
|
67.8
|
L
 1%
H
67.3
68.1
|
L
 -2.7%
H
66.0
69
|
L
 2.6%
H
63.8
69.7
|
L
 -13.1%
H
61.8
82.4
|
L
 -23.6%
H
61.8
92.6
|
L
 -17.5%
H
61.8
101.1
|
L
 -3.7%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,169.4
|
24.1
|
L
 -0.1%
H
23.7
24.2
|
L
 0.5%
H
23.2
25.4
|
L
 17.7%
H
19.9
25.4
|
L
 -36.0%
H
19.2
39.7
|
L
 -26.0%
H
19.2
48.3
|
L
 58.5%
H
12.2
48.3
|
L
 -13.3%
H
9.6
48.3
|
L
 97.0%
H
9.6
48.3
|
| Avanos Medical Inc |
|
1,167.9
|
24.9
|
L
 0.0%
H
24.9
25.0
|
L
H
24.9
25.0
|
L
 -0.2%
H
24.5
25.1
|
L
 75.8%
H
14.0
25.5
|
L
 103.3%
H
9.3
25.5
|
L
 -0.5%
H
9.3
26.6
|
L
 -31.2%
H
9.3
38.8
|
L
 -27.7%
H
9.3
73.0
|
| Baxter International |
|
11,682.5
|
22.6
|
L
 0.7%
H
22.4
22.7
|
L
 -0.1%
H
21.7
23.5
|
L
 11.4%
H
19.4
23.5
|
L
 31.9%
H
16.2
23.5
|
L
 -23.8%
H
15.7
29.5
|
L
 -50.4%
H
15.7
50.2
|
L
 -71.9%
H
15.7
89.7
|
L
 -51.5%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
41,865.6
|
151.9
|
L
 0.7%
H
150.2
152.9
|
L
 -3.9%
H
148.2
159.5
|
L
 2.8%
H
140.1
159.5
|
L
 -1.5%
H
140.1
160.0
|
L
 -14.4%
H
140.1
213.1
|
L
 -41.0%
H
140.1
287.3
|
L
 -37.7%
H
140.1
287.3
|
L
 -11.3%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
2,087.9
|
8.0
|
L
 -0.5%
H
7.5
8.1
|
L
 3.9%
H
7.2
9.2
|
L
 48.1%
H
5.3
9.7
|
L
 94.2%
H
3.8
9.7
|
L
 326.7%
H
1.3
9.7
|
L
 253.1%
H
0.7
9.7
|
L
 -37.7%
H
0.7
13.6
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
7,924.4
|
296.1
|
L
 -0.4%
H
296.0
302.2
|
L
 -0.3%
H
281.8
302.2
|
L
 1.8%
H
270
305
|
L
 6.0%
H
236.7
319.9
|
L
 13.9%
H
236.7
343.1
|
L
 -24.0%
H
211.4
431.8
|
L
 -56.1%
H
211.4
832.7
|
L
 105.9%
H
142.1
832.7
|
| Bausch + Lomb Corp |
|
5,786.6
|
16.2
|
L
 -3.0%
H
16.0
16.8
|
L
 -5.4%
H
16.0
17.5
|
L
 6.4%
H
14.7
17.5
|
L
 -1.6%
H
14.7
17.5
|
L
 14.3%
H
13.1
18.9
|
L
 -17.7%
H
10.5
21.7
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
66,544.1
|
44.8
|
L
 -0.5%
H
44.2
45.5
|
L
 -0.8%
H
43.8
46.4
|
L
 -7.4%
H
42.3
48.7
|
L
 -27.5%
H
42.3
66.9
|
L
 -56.9%
H
42.3
109.5
|
L
 -15.0%
H
42.3
109.5
|
L
 2.7%
H
35.0
109.5
|
L
 87.3%
H
19.7
109.5
|
| Cardinal Health |
|
55,225.7
|
235.8
|
L
 0.9%
H
232.1
236.3
|
L
 -1.3%
H
231.8
243.2
|
L
 9.0%
H
217.0
243.2
|
L
 9.4%
H
180.5
243.2
|
L
 45.4%
H
137.8
243.2
|
L
 151.7%
H
85.1
243.2
|
L
 312.4%
H
45.9
243.2
|
L
 193.4%
H
39.1
243.2
|
| Conmed Corp |
|
1,158.6
|
38.5
|
L
 4.9%
H
36.4
38.8
|
L
 13.8%
H
32.6
38.8
|
L
 6.0%
H
31.4
38.8
|
L
 4.7%
H
31.4
40.6
|
L
 -28.2%
H
31.4
56.6
|
L
 -71.2%
H
31.4
137.9
|
L
 -71.6%
H
31.4
159.1
|
L
 -21.0%
H
31.4
159.1
|
| Cooper Companies |
|
13,788.7
|
70.7
|
L
 -0.5%
H
70.4
71.4
|
L
 -4.7%
H
69.2
74.3
|
L
 4.5%
H
64.9
74.5
|
L
 -0.7%
H
58.9
74.5
|
L
 -7.8%
H
58.9
89.8
|
L
 -26.2%
H
58.9
112.4
|
L
 -31.2%
H
58.9
115.9
|
L
 55.5%
H
39.7
115.9
|
| Danaher |
|
140,881.7
|
199.1
|
L
 1.6%
H
195.1
199.8
|
L
 0.6%
H
189.8
199.8
|
L
 8.4%
H
174.2
199.8
|
L
 5.0%
H
160.9
200.5
|
L
 -3.1%
H
160.9
242.8
|
L
 -15.1%
H
160.9
281.7
|
L
 -28.3%
H
160.9
334.0
|
L
 146.2%
H
75.7
334.0
|
| Edwards Lifesciences |
|
53,094.5
|
92.2
|
L
 1.0%
H
90.7
92.3
|
L
 -2.3%
H
90.7
96.3
|
L
 7.3%
H
83.2
96.3
|
L
 18.4%
H
76.5
96.3
|
L
 17.0%
H
72.3
96.3
|
L
 0.6%
H
58.9
96.3
|
L
 -14.2%
H
58.9
131.7
|
L
 164.1%
H
27.0
131.7
|
| Glaukos Corp |
|
8,969.8
|
152.7
|
L
 -1.5%
H
143.1
156.6
|
L
 3.0%
H
143.1
156.6
|
L
 24.7%
H
122.7
156.6
|
L
 31.2%
H
99.5
156.6
|
L
 43.3%
H
73.2
156.6
|
L
 115.9%
H
59.2
163.7
|
L
 99.7%
H
33.3
163.7
|
L
 422.3%
H
23.1
163.7
|
| Globus Medical Inc (Class A) |
|
10,603.0
|
78.1
|
L
 1.9%
H
76.1
78.8
|
L
 -2.5%
H
74.9
82.0
|
L
 -3.4%
H
74.7
86.3
|
L
 -13.6%
H
74.5
97.4
|
L
 35.1%
H
51.8
101.4
|
L
 30.7%
H
43.4
101.4
|
L
 -3.1%
H
43.4
101.4
|
L
 214.1%
H
19.3
101.4
|
| Haemonetics Corp |
|
3,462.5
|
76.2
|
L
 1.6%
H
74.7
76.6
|
L
 1.5%
H
71.8
76.9
|
L
 -3.3%
H
71.8
82.0
|
L
 32.9%
H
51
82.0
|
L
 -2.5%
H
47.3
87.3
|
L
 -10.7%
H
47.3
98.0
|
L
 20.0%
H
43.5
98.0
|
L
 152.1%
H
29.2
142.1
|
| Herbalife Nutrition Ltd |
|
1,363.3
|
13.2
|
L
 1.9%
H
12.8
13.3
|
L
 0.3%
H
12.5
13.5
|
L
 16.2%
H
11.3
13.5
|
L
 -13.7%
H
11.2
17.5
|
L
 26.8%
H
7.6
20.4
|
L
 6.9%
H
5.0
20.4
|
L
 -75.2%
H
5.0
54.5
|
L
 -56.9%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
1,491.4
|
51.8
|
L
 0.5%
H
50.0
52.5
|
L
 10.2%
H
46.5
52.5
|
L
 22.4%
H
39.7
52.5
|
L
 -4.2%
H
38.9
59.0
|
L
 -62.8%
H
38.9
147.0
|
L
 -83.3%
H
38.9
330
|
L
 -72.1%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
3,180.9
|
93.7
|
L
 1.9%
H
92.0
93.9
|
L
 -1.5%
H
90.2
95.3
|
L
 2.5%
H
87.0
96.2
|
L
 10.1%
H
77.1
96.2
|
L
 -23.1%
H
62
121.8
|
L
 10.6%
H
62
146.4
|
L
 0.7%
H
50.1
146.4
|
L
 191.3%
H
18.1
146.4
|
| McKesson |
|
94,360.0
|
806.0
|
L
 1.7%
H
791.2
806.5
|
L
 2.5%
H
776
823.9
|
L
 2.0%
H
744.5
823.9
|
L
 -6.9%
H
723.7
875.5
|
L
 12.8%
H
637
999
|
L
 94.3%
H
395.3
999
|
L
 326.2%
H
186.6
999
|
L
 318.1%
H
106.1
999
|
| Medtronic |
|
107,357.4
|
83.9
|
L
 1.8%
H
82.6
84.2
|
L
 0.8%
H
81.1
86.0
|
L
 4.5%
H
77.6
86.0
|
L
 -3.8%
H
73.3
88.7
|
L
 -6.2%
H
73.3
106.3
|
L
 -3.0%
H
68.9
106.3
|
L
 -34.6%
H
68.9
135.9
|
L
 -5.1%
H
68.9
135.9
|
| Mettler-Toledo International |
|
26,192.5
|
1,296.2
|
L
 0.6%
H
1281.3
1303.5
|
L
 -0.9%
H
1245
1318
|
L
 14.4%
H
1113.9
1321.5
|
L
 -2.2%
H
1023.1
1365.8
|
L
 4.9%
H
1023.1
1525.2
|
L
 0.2%
H
928.5
1546.9
|
L
 -9.7%
H
928.5
1714.8
|
L
 247.5%
H
372.5
1714.8
|
| Envista Holdings Corp |
|
4,216.3
|
25.9
|
L
 0.6%
H
25.2
26.2
|
L
 -6.2%
H
25.2
27.9
|
L
 7.7%
H
23.8
27.9
|
L
 -1.8%
H
22.4
29.5
|
L
 25.1%
H
18.8
30.4
|
L
 -23.4%
H
14.2
36.1
|
L
 -40.6%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
261.9
|
3.4
|
L
 3.6%
H
3.3
3.5
|
L
 -4.7%
H
3.1
3.8
|
L
 24.8%
H
2.7
3.8
|
L
 21.7%
H
2.5
4.7
|
L
 -58.7%
H
1.8
8.4
|
L
 -81.1%
H
1.8
28.4
|
L
 -92.4%
H
1.8
49.1
|
L
 -91.0%
H
1.8
49.2
|
| Penumbra Inc |
|
12,511.3
|
318.1
|
L
 0.1%
H
317.4
318.5
|
L
 -0.2%
H
316.5
320.0
|
L
 -0.4%
H
314.8
321.8
|
L
 -3.5%
H
314.8
335.2
|
L
 30.4%
H
221.3
362.4
|
L
 -2.8%
H
148
362.4
|
L
 15.0%
H
114.9
362.4
|
L
 425.9%
H
56.1
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
26,632.3
|
27.4
|
L
 0.5%
H
27.3
27.6
|
L
 -1.2%
H
27.2
28.5
|
L
 6.7%
H
25.6
28.5
|
L
 -3.2%
H
25.1
30.0
|
L
 11.1%
H
23.9
33.4
|
L
 26.3%
H
17.8
33.4
|
L
 -40.9%
H
11.8
48.7
|
L
 13.8%
H
11.8
61.2
|
| Qiagen NV |
|
8,561.4
|
41.5
|
L
 -1.1%
H
41.4
42.3
|
L
 3.5%
H
37.7
44.0
|
L
 12.1%
H
36.2
44.0
|
L
 1.5%
H
32.5
44.0
|
L
 -18.8%
H
32.5
57.8
|
L
 -17.5%
H
32.5
57.8
|
L
 -26.4%
H
32.5
64.7
|
L
 61.6%
H
25.5
65.9
|
| ResMed |
|
29,572.6
|
203.9
|
L
 -2.2%
H
203.4
209.4
|
L
 -2.8%
H
203.4
222.4
|
L
 5.3%
H
184.7
222.4
|
L
 -10.9%
H
180.3
232.3
|
L
 -21%
H
180.3
293.8
|
L
 -5.9%
H
132.2
293.8
|
L
 -17.7%
H
132.2
301.3
|
L
 216.0%
H
56.6
301.3
|
| Steris PLC |
|
21,050.9
|
216
|
L
H
215.6
217.6
|
L
 -1.0%
H
207.2
218.1
|
L
 3.8%
H
198.0
218.7
|
L
 -3.0%
H
195.1
227.9
|
L
 -6.4%
H
195.1
269.4
|
L
 -3.2%
H
195.1
269.4
|
L
 2.3%
H
159.2
269.4
|
L
 212.3%
H
63.8
269.4
|
| Stevanato Grp Spa |
|
5,348.1
|
19.6
|
L
 -0.8%
H
19.4
20.3
|
L
 3.1%
H
18.7
20.3
|
L
 14.0%
H
16.3
20.3
|
L
 44.9%
H
13.5
20.3
|
L
 -24.5%
H
12.9
28
|
L
 -38.6%
H
12.9
36.3
|
L
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
126,424.7
|
329.8
|
L
 0.8%
H
327
331.6
|
L
 1.0%
H
318.0
334.0
|
L
 6.8%
H
299.2
334.8
|
L
 -2.8%
H
281
352.8
|
L
 -16.5%
H
281
404.9
|
L
 11.7%
H
250.0
406.2
|
L
 24.7%
H
188.8
406.2
|
L
 169.7%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,940.7
|
30.7
|
L
 1.0%
H
30.5
30.8
|
L
 1.5%
H
29.9
31.0
|
L
 -0.7%
H
28.6
31.0
|
L
 -8.3%
H
28.6
34.7
|
L
 -1.2%
H
28.6
38.8
|
L
 1.3%
H
21.5
38.8
|
L
 -29.5%
H
21.5
44.2
|
L
 -10.9%
H
21.5
52.3
|
| Teleflex Incorporated |
|
6,008.8
|
135.7
|
L
 1.3%
H
134.3
137.1
|
L
 1.3%
H
129.6
137.1
|
L
 2.7%
H
120.9
137.1
|
L
 14.7%
H
118.5
139.7
|
L
 13.2%
H
100.2
139.7
|
L
 -43.2%
H
100.2
263.0
|
L
 -67.9%
H
100.2
424.4
|
L
 -25.5%
H
100.2
449.4
|
| Thermo Fisher |
|
195,863.1
|
527.1
|
L
 0.5%
H
522.6
533.1
|
L
 0.7%
H
506.8
533.1
|
L
 9.3%
H
457.6
533.1
|
L
 6.2%
H
435.3
538.4
|
L
 22.4%
H
403.4
644.0
|
L
 2.0%
H
385.5
644.0
|
L
 1.9%
H
385.5
672.3
|
L
 245.2%
H
139.1
672.3
|
| Waters |
|
36,960.1
|
376.4
|
L
 -0.2%
H
373.2
380.3
|
L
 -0.8%
H
367.1
383.5
|
L
 3.7%
H
351.8
383.5
|
L
 17.6%
H
287.2
385.3
|
L
 6.6%
H
275.1
414.2
|
L
 42.2%
H
231.9
423.6
|
L
 1.9%
H
231.9
428.2
|
L
 156.9%
H
133.4
428.2
|
| West Pharma Services |
|
24,988.8
|
353.7
|
L
 -1.1%
H
352.7
358.0
|
L
 -3.3%
H
349.4
366.4
|
L
 6.9%
H
321.9
367.7
|
L
 37.9%
H
254.6
367.7
|
L
 54.3%
H
206.8
367.7
|
L
 -6.3%
H
187.4
415.7
|
L
 -5.5%
H
187.4
475.4
|
L
 357.7%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
17,670.9
|
91.3
|
L
 2.4%
H
89.6
91.9
|
L
 4.4%
H
86.3
91.9
|
L
 3.6%
H
83.7
93.3
|
L
 -1.9%
H
79.1
97.8
|
L
 -4%
H
79.1
108.3
|
L
 -35.9%
H
79.1
144.1
|
L
 -39.1%
H
79.1
155.7
|
L
 -22.3%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
8,593.5
|
298.5
|
L
 1.8%
H
298.5
298.5
|
L
 0.7%
H
293.4
298.5
|
L
 -1.9%
H
289.2
298.5
|
L
 7.8%
H
244.5
304.2
|
L
 19.4%
H
244.5
321.1
|
L
 -10.1%
H
225.3
373.4
|
L
 -10.1%
H
225.3
373.4
|
L
 -10.1%
H
225.3
373.4
|
| Haleon PLC (ADR) |
|
42,981.1
|
9.8
|
L
 0.5%
H
9.7
9.8
|
L
 -0.6%
H
9.6
10.0
|
L
 7.5%
H
8.8
10.0
|
L
 -0.8%
H
8.7
10.0
|
L
 -3.5%
H
8.7
11.3
|
L
 20.2%
H
7.7
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
12,527.0
|
112.3
|
L
 -0.6%
H
111.8
114.2
|
L
 -1.3%
H
108.0
114.2
|
L
 10.9%
H
96.9
116.2
|
L
 25.1%
H
81.2
116.2
|
L
 9.7%
H
81.2
118.3
|
L
 -4.0%
H
79.5
132.0
|
L
 -27.1%
H
79.5
203.2
|
L
 108.1%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
1.9
|
0.7
|
L
 1.4%
H
0.7
0.7
|
L
H
0.6
0.8
|
L
 -64.9%
H
0.6
2.1
|
L
 -67.3%
H
0.6
3.2
|
L
 -94.2%
H
0.6
27.4
|
L
 -99.8%
H
0.6
391.7
|
L
 -100.0%
H
0.6
4976
|
L
 -100.0%
H
0.6
109078.8
|
| Ainos Inc |
|
13.9
|
1.9
|
L
 -1.1%
H
1.8
2.0
|
L
 1.1%
H
1.8
2.1
|
L
H
1.7
2.3
|
L
 16.7%
H
1.5
3.9
|
L
 -39.8%
H
1.3
4.5
|
L
 -89.2%
H
1.3
30.5
|
L
 -99.5%
H
1.3
450
|
L
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
305.5
|
4.3
|
L
H
4.2
4.5
|
L
 -4.2%
H
4.1
4.8
|
L
 -12.9%
H
4.1
5.7
|
L
 64.0%
H
2.3
5.8
|
L
 -13.2%
H
1.5
12
|
L
 -48.5%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,851.9
|
179.5
|
L
 0.7%
H
175
181.2
|
L
 -2.8%
H
173.7
191.0
|
L
 5.3%
H
165.5
191.0
|
L
 3.6%
H
151.6
200.4
|
L
 -12.2%
H
122
208.3
|
L
 -47.8%
H
122
413.2
|
L
 -71.4%
H
122
737.5
|
L
 116.4%
H
82
737.5
|
| Angiodynamic Inc |
|
528.5
|
12.8
|
L
 -1.0%
H
12.6
12.9
|
L
 -2.3%
H
12.6
13.5
|
L
 4.2%
H
11.6
13.8
|
L
 30.5%
H
9.7
13.8
|
L
 34.9%
H
8.4
14.0
|
L
 33.0%
H
5.3
14.0
|
L
 -54.5%
H
5.3
32
|
L
 -11.8%
H
5.3
32
|
| Anika Therapeutics Inc |
|
207.6
|
15.6
|
L
 -3.1%
H
14.9
16.1
|
L
 1.6%
H
14.9
16.5
|
L
 4.4%
H
13.8
16.5
|
L
 5.7%
H
11.9
16.5
|
L
 32.4%
H
7.9
16.5
|
L
 -37.8%
H
7.9
29.1
|
L
 -63.8%
H
7.9
45.8
|
L
 -70.7%
H
7.9
75.7
|
| Apyx Medical Corp |
|
184.4
|
4.4
|
L
 -1.8%
H
4.3
4.5
|
L
 1.9%
H
4.1
4.5
|
L
 -5.0%
H
3.9
5.0
|
L
 10.6%
H
2.8
5.1
|
L
 102.8%
H
1.6
5.1
|
L
 -16.6%
H
0.8
6.5
|
L
 -54.5%
H
0.8
17.5
|
L
 143.3%
H
0.8
17.5
|
| Accuray Inc |
|
28.6
|
0.2
|
L
 -7.7%
H
0.2
0.3
|
L
 -7.7%
H
0.2
0.3
|
L
 -27.3%
H
0.2
0.4
|
L
 -38.5%
H
0.2
0.5
|
L
 -83.0%
H
0.2
2.1
|
L
 -93.7%
H
0.2
4.3
|
L
 -94.7%
H
0.2
5.9
|
L
 -95.4%
H
0.2
6.4
|
| Alphatec Holdings Inc |
|
1,473.3
|
9.6
|
L
 0.7%
H
9.3
9.6
|
L
 7.4%
H
8.8
9.6
|
L
 17.8%
H
7.9
9.6
|
L
 -12.1%
H
6.8
11.8
|
L
 -17.3%
H
6.8
23.3
|
L
 -46.9%
H
4.9
23.3
|
L
 -32.3%
H
4.9
23.3
|
L
 120.2%
H
1.2
23.3
|
| Atricure Inc |
|
1,736.0
|
34.3
|
L
 -0.8%
H
33.4
34.8
|
L
 7.8%
H
31.6
34.8
|
L
 24.6%
H
26.8
34.8
|
L
 21.4%
H
25.4
34.8
|
L
 6.9%
H
25.4
43.2
|
L
 -31.1%
H
18.9
59.6
|
L
 -58.3%
H
18.9
89.2
|
L
 125.5%
H
13.5
89.2
|
| Axogen Inc |
|
2,158.0
|
40.6
|
L
 -7.0%
H
39.6
43.6
|
L
 -11.6%
H
39.6
47.0
|
L
 -1.8%
H
39.6
47.0
|
L
 27.0%
H
31.8
47.0
|
L
 236.8%
H
11.3
47.0
|
L
 380.8%
H
3.5
47.0
|
L
 97.6%
H
3.5
47.0
|
L
 431.2%
H
3.5
56.9
|
| Bone Biologics Corp |
|
2.5
|
1.4
|
L
 0.7%
H
1.3
1.4
|
L
 -2.1%
H
1.3
1.5
|
L
 12.1%
H
1.2
1.5
|
L
 10.3%
H
1.2
1.5
|
L
 -54.0%
H
1.1
4.1
|
L
 -98.0%
H
1.1
85.0
|
L
 -100.0%
H
1.1
10255.5
|
L
 -100.0%
H
1.1
169920
|
| BioAffinity Tech Inc |
|
4.8
|
0.8
|
L
 -1.3%
H
0.7
0.8
|
L
 -7.2%
H
0.7
0.8
|
L
 -49.3%
H
0.7
1.7
|
L
 -77.0%
H
0.7
3.3
|
L
 -91.7%
H
0.7
13.5
|
L
 -98.5%
H
0.7
108.6
|
L
H
0.7
466.5
|
L
H
0.7
466.5
|
| Bluejay Diagnostics Inc |
|
1.5
|
1.5
|
L
 3.6%
H
1.3
1.5
|
L
 27.2%
H
1.1
2.1
|
L
 -67.7%
H
1.0
4.9
|
L
 -18.5%
H
1.0
7
|
L
 -78.0%
H
1.0
16.7
|
L
 -100.0%
H
1.0
22368
|
L
H
1.0
200000
|
L
H
1.0
200000
|
| Biolife Soln Inc |
|
1,376.8
|
28.2
|
L
 -0.2%
H
27.7
28.5
|
L
 0.3%
H
27.0
28.7
|
L
 5.7%
H
24.8
30
|
L
 42.8%
H
19.6
30
|
L
 24.0%
H
17.9
30
|
L
 32.4%
H
8.9
30
|
L
 -41.1%
H
8.9
60.7
|
L
 1694.9%
H
1.4
60.7
|
| Biomerica Inc |
|
5.2
|
1.7
|
L
 2.4%
H
1.7
1.7
|
L
 -3.4%
H
1.6
1.7
|
L
 -16.3%
H
1.6
2.2
|
L
 -20.7%
H
1.6
2.5
|
L
 -49.4%
H
1.6
4.6
|
L
 38.5%
H
0.2
4.9
|
L
 -54.9%
H
0.2
7.4
|
L
 12.7%
H
0.2
23.4
|
| Bruker Corp |
|
9,142.7
|
60.1
|
L
 -0.9%
H
58.9
60.8
|
L
 -2.6%
H
55.9
61.9
|
L
 9.4%
H
52.9
63.0
|
L
 59.8%
H
33.8
64.5
|
L
 37.8%
H
28.5
64.5
|
L
 -19.1%
H
28.5
94.9
|
L
 -25.0%
H
28.5
94.9
|
L
 153.6%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
8.7
|
0.3
|
L
H
0.3
0.4
|
L
 -15%
H
0.3
0.4
|
L
 -10.5%
H
0.3
0.4
|
L
 41.7%
H
0.2
0.7
|
L
 -78.8%
H
0.2
1.9
|
L
 -90.4%
H
0.2
3.7
|
L
 -98.5%
H
0.2
28.8
|
L
 -100.0%
H
0.2
20040
|
| Biosig Tech Inc |
|
95.9
|
0.9
|
L
H
0.9
1.0
|
L
 -5.2%
H
0.9
1.2
|
L
H
0.7
1.2
|
L
 -13.2%
H
0.7
1.6
|
L
 -84.3%
H
0.7
7.4
|
L
 -24.0%
H
0.1
14.1
|
L
 -76.3%
H
0.1
14.1
|
L
 -74.8%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
804.8
|
11.9
|
L
 -2.8%
H
11.6
12.1
|
L
 13.4%
H
10.5
12.3
|
L
 31.3%
H
8.4
12.3
|
L
 31.1%
H
7.8
12.3
|
L
 60.8%
H
5.8
12.3
|
L
 245.3%
H
2.8
14.4
|
L
 -27.3%
H
0.8
17.6
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
604.3
|
15.1
|
L
 -0.2%
H
14.9
15.2
|
L
 -0.9%
H
14.7
16.3
|
L
 6.4%
H
13.9
16.3
|
L
 8.2%
H
13.8
17.4
|
L
 376.6%
H
2.8
17.4
|
L
 2496.6%
H
0.5
17.4
|
L
 527.5%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
5.4
|
1.8
|
L
 -1.1%
H
1.8
1.9
|
L
 -8.0%
H
1.8
2.1
|
L
 -5.2%
H
1.8
2.3
|
L
H
1.3
2.6
|
L
 -57.3%
H
1.0
7.9
|
L
 -94.4%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
1,472.8
|
28.5
|
L
 -2.1%
H
28.1
29.3
|
L
 -2.3%
H
27.3
29.9
|
L
 21.5%
H
22.7
30
|
L
 77.6%
H
15.8
30
|
L
 38.2%
H
11.0
30
|
L
 193.6%
H
4.8
34.8
|
L
 -67.4%
H
4.8
89.2
|
L
 476.0%
H
0.8
99.8
|
| Celcuity Inc |
|
5,246.3
|
107.6
|
L
 -5.2%
H
107.3
113.5
|
L
 -0.3%
H
106.2
117.2
|
L
 21.9%
H
82.6
117.2
|
L
 -8.2%
H
82.6
151.0
|
L
 689.9%
H
13.4
151.0
|
L
 982.3%
H
7.6
151.0
|
L
 332.6%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
5.9
|
0.9
|
L
 -3.2%
H
0.9
0.9
|
L
 -24.8%
H
0.9
1.2
|
L
 -56.9%
H
0.8
4.7
|
L
 -57.5%
H
0.8
4.7
|
L
 -68.3%
H
0.8
6.3
|
L
 -81.0%
H
0.8
10.3
|
L
 -99.4%
H
0.8
200
|
L
 -100.0%
H
0.8
525000
|
| Cerus Corp |
|
625.2
|
3.1
|
L
 -1.0%
H
3.0
3.2
|
L
 -1.3%
H
3.0
3.5
|
L
 21.9%
H
2.4
3.5
|
L
 65.1%
H
1.9
3.5
|
L
 101.3%
H
1.2
3.5
|
L
 43.1%
H
1.1
3.5
|
L
 -40.8%
H
1.1
8.1
|
L
 -51.6%
H
1.1
8.9
|
| Check-Cap Ltd |
|
9.4
|
1.2
|
L
 -0.8%
H
1.2
1.2
|
L
 7.0%
H
1.1
1.2
|
L
 -8.3%
H
1.1
1.5
|
L
 -27.4%
H
1.1
2.1
|
L
 56.4%
H
0.6
3.9
|
L
 -57.2%
H
0.6
4.6
|
L
 -94.7%
H
0.6
26.2
|
L
 -99.6%
H
0.6
820.8
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
7.0
|
0.4
|
L
 2.8%
H
0.4
0.4
|
L
 8.8%
H
0.4
0.4
|
L
 2.8%
H
0.3
0.4
|
L
 -2.6%
H
0.3
0.5
|
L
 -73.8%
H
0.3
3.2
|
L
 -95.1%
H
0.3
7.9
|
L
 -98.2%
H
0.3
23
|
L
 -97.9%
H
0.3
24.3
|
| ClearPoint Neuro Inc |
|
524.8
|
17.5
|
L
 -2.1%
H
17.1
17.9
|
L
 -6.5%
H
16.8
18.9
|
L
 27.3%
H
13.1
19.6
|
L
 101.6%
H
8.6
19.6
|
L
 46.3%
H
8.3
30.1
|
L
 164.0%
H
4.1
30.1
|
L
 -5.6%
H
4.1
30.1
|
L
 143.1%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
90.9
|
1.3
|
L
 0.8%
H
1.2
1.3
|
L
 4.7%
H
1.2
1.4
|
L
 -10.1%
H
1.2
1.6
|
L
 -15.8%
H
1.2
2
|
L
 -68.0%
H
1.2
4.6
|
L
 -10.1%
H
0.9
6.4
|
L
 -79.7%
H
0.9
8.6
|
L
 -99.6%
H
0.7
430.6
|
| Castle Biosciences Inc |
|
719.4
|
23.7
|
L
 -3.4%
H
23.4
24.7
|
L
 -1.6%
H
23.3
24.8
|
L
 12.5%
H
19.9
25.0
|
L
 2.6%
H
17.7
25.7
|
L
 19.6%
H
14.6
44.3
|
L
 19.6%
H
12.1
44.3
|
L
 -67.7%
H
9.3
78.6
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
596.6
|
4.6
|
L
 0.7%
H
4.5
4.7
|
L
 0.7%
H
4.3
4.7
|
L
 14.1%
H
3.7
4.7
|
L
 2.0%
H
3.3
5.0
|
L
 29.8%
H
3.1
6.2
|
L
 -47.9%
H
2.4
9.9
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
23.9
|
0.4
|
L
 2.7%
H
0.4
0.4
|
L
 -2.6%
H
0.4
0.5
|
L
 -7.3%
H
0.4
0.6
|
L
 -37.7%
H
0.4
0.7
|
L
 -66.7%
H
0.4
1.2
|
L
 -89.1%
H
0.4
4.3
|
L
 -95.2%
H
0.4
9.8
|
L
 -92.2%
H
0.4
15.0
|
| Citius Pharma Inc |
|
15.9
|
0.6
|
L
 3.6%
H
0.6
0.6
|
L
H
0.6
0.6
|
L
 5.5%
H
0.5
0.6
|
L
 -27.5%
H
0.5
1.0
|
L
 -64.4%
H
0.5
2.2
|
L
 -98.1%
H
0.1
31.8
|
L
 -98.9%
H
0.1
58.8
|
L
 -99.8%
H
0.1
450.0
|
| CVRx Inc |
|
144.1
|
5.4
|
L
 4.4%
H
5.2
5.4
|
L
 -3.0%
H
5.0
5.9
|
L
 12.4%
H
4.8
6.0
|
L
 -24.2%
H
4.8
8.5
|
L
 -22.0%
H
4.4
11.3
|
L
 -60.0%
H
4.3
33.1
|
L
 -70.7%
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
449.1
|
13.0
|
L
 -3.8%
H
12.7
13.6
|
L
 -1.4%
H
12.7
13.7
|
L
 16.3%
H
11.0
13.7
|
L
 29.6%
H
10.0
13.7
|
L
 3.7%
H
8.1
13.7
|
L
 129.0%
H
2.3
18.2
|
L
 19.0%
H
2.3
18.2
|
L
 -100.0%
H
2.3
795025000
|
| Alpha Tau Medical Ltd |
|
1,148.0
|
12.7
|
L
 -2.1%
H
12.0
13.4
|
L
 -3.9%
H
12.0
14.1
|
L
 37.6%
H
9.2
14.1
|
L
 74.4%
H
7.2
14.1
|
L
 303.5%
H
2.9
14.1
|
L
 207.7%
H
1.8
14.1
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
28,925.0
|
75.0
|
L
 2.7%
H
73.3
75.6
|
L
 5.2%
H
69.7
75.6
|
L
 0.3%
H
67.3
76.3
|
L
 17.1%
H
56.7
78.9
|
L
 -12.3%
H
54.1
90.0
|
L
 -42.6%
H
54.1
142
|
L
 -32.0%
H
54.1
164.9
|
L
 280.1%
H
10.7
164.9
|
| Daxor Corp |
|
61.5
|
10.5
|
L
 4.2%
H
10.5
10.5
|
L
 1.5%
H
10.1
11.1
|
L
 7.9%
H
9.3
11.1
|
L
 11.3%
H
9.1
12.3
|
L
 10.8%
H
8.6
14.8
|
L
 9.7%
H
6.6
14.8
|
L
 -5.8%
H
6.6
14.8
|
L
 31.5%
H
3.4
24.1
|
| ElectroCore Inc |
|
54.8
|
6.6
|
L
 -0.6%
H
6.5
7.1
|
L
 -24.7%
H
6.1
9.5
|
L
 -33.5%
H
6.1
10.5
|
L
 8.6%
H
5.7
10.5
|
L
 -12.6%
H
4.2
10.5
|
L
 35.8%
H
3.9
19.5
|
L
 -61.1%
H
2.9
19.5
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
3,035.0
|
20.9
|
L
 2.8%
H
19.3
21.0
|
L
 26.7%
H
16.3
21.0
|
L
 21.2%
H
15.5
28.2
|
L
 131.7%
H
8.6
28.2
|
L
 505.8%
H
2.9
28.2
|
L
 -93.2%
H
2.7
704.0
|
L
 -98.2%
H
2.7
1217.3
|
L
 -99.9%
H
2.7
22919.6
|
| Embecta Corp |
|
192.2
|
3.2
|
L
 1.9%
H
3.2
3.3
|
L
 -3.3%
H
3.1
3.4
|
L
 0.9%
H
3.0
3.5
|
L
 -63.4%
H
2.8
9.9
|
L
 -69.8%
H
2.8
15.6
|
L
 -84.5%
H
2.8
23.8
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
2,590.8
|
88.0
|
L
 -0.8%
H
86.1
90.2
|
L
 -1.4%
H
86.1
92.8
|
L
 10.8%
H
78.1
92.8
|
L
 46.3%
H
60
92.8
|
L
 91.5%
H
33.4
92.8
|
L
 30.8%
H
17
92.8
|
L
 5.8%
H
17
93.8
|
L
H
7.6
93.8
|
| EDAP TMS S.A. (ADR) |
|
203.9
|
5.4
|
L
 -0.7%
H
5.4
5.5
|
L
 5.0%
H
5.2
5.6
|
L
 16.7%
H
4.7
5.6
|
L
 64.9%
H
3.1
5.6
|
L
 244.3%
H
1.2
5.6
|
L
 -40.2%
H
1.2
9.5
|
L
 -14.5%
H
1.2
12.7
|
L
 68.4%
H
1.2
12.7
|
| GlucoTrack Inc |
|
2.6
|
0.4
|
L
 7.7%
H
0.4
0.4
|
L
 31.3%
H
0.3
0.4
|
L
 5%
H
0.3
0.5
|
L
 -36.4%
H
0.3
1.3
|
L
 -92.8%
H
0.3
14.1
|
L
 -100.0%
H
0.3
5940
|
L
 -100.0%
H
0.3
46800
|
L
 -100.0%
H
0.3
468000
|
| GE HealthCare Tech |
|
29,431.5
|
64.7
|
L
H
64.2
65.3
|
L
 -1.3%
H
63.5
66.5
|
L
 1.5%
H
60.0
66.5
|
L
 -11.6%
H
58.8
76.0
|
L
 -15.4%
H
58.8
89.8
|
L
 -19.8%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
27.7
|
6.1
|
L
 -1.4%
H
6.1
6.4
|
L
 -0.2%
H
6.1
6.7
|
L
 -1.0%
H
5.8
6.7
|
L
 42.5%
H
4.3
7.5
|
L
 33.5%
H
3.8
9.4
|
L
 -89.5%
H
2.8
58.8
|
L
 -92.5%
H
2.8
87.5
|
L
 -78.1%
H
2.8
87.5
|
| Heart Test Laboratories Inc |
|
9.0
|
2.7
|
L
 2.2%
H
2.6
2.8
|
L
 -1.8%
H
2.6
3.0
|
L
 45.7%
H
1.7
3.8
|
L
 31.7%
H
1.6
3.8
|
L
 -52.2%
H
1.6
5.7
|
L
 -97.0%
H
1.6
99
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
102.2
|
1.8
|
L
 -4.4%
H
1.7
1.9
|
L
 -2.2%
H
1.7
1.9
|
L
 24.1%
H
1.4
1.9
|
L
 -7.4%
H
1.2
2.4
|
L
 -80%
H
1.2
25.5
|
L
 -100.0%
H
1.2
10072.5
|
L
 -100.0%
H
1.2
616875
|
L
 -100.0%
H
1.2
27168750
|
| Henry Schein |
|
9,614.6
|
84.4
|
L
 0.6%
H
83.7
85.5
|
L
 -2.4%
H
82.3
87.7
|
L
 7.0%
H
78.6
87.7
|
L
 12.0%
H
68.7
87.7
|
L
 13.2%
H
61.9
89.3
|
L
 5.4%
H
60.0
89.3
|
L
 9.9%
H
60.0
92.7
|
L
 19.2%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
108.2
|
1.1
|
L
 -2.7%
H
1.1
1.1
|
L
 -16.2%
H
1.1
1.3
|
L
 -22.1%
H
1.1
1.7
|
L
 -9.9%
H
1.1
1.9
|
L
 39.7%
H
0.8
2.2
|
L
 -48.1%
H
0.5
3.3
|
L
 -89.1%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,461.8
|
18.8
|
L
 2.2%
H
18.3
18.9
|
L
 4.1%
H
17.0
18.9
|
L
 10.0%
H
16.8
18.9
|
L
 89.8%
H
9.7
18.9
|
L
 42.7%
H
8.7
18.9
|
L
 -53.9%
H
8.7
46.8
|
L
 -72.5%
H
8.7
76.7
|
L
 -53.9%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
12.5
|
3.7
|
L
 -6.2%
H
3.6
3.9
|
L
 -31.9%
H
3.6
5.1
|
L
 43.7%
H
2.1
9.5
|
L
 -62.3%
H
2.1
11.5
|
L
 -88.0%
H
2.1
42
|
L
 -89.2%
H
2.1
49.8
|
L
 -98.7%
H
2.1
372
|
L
 -89.4%
H
2.1
480
|
| SeaStar Medical Holding Corp |
|
19.8
|
5.0
|
L
 1.0%
H
4.7
5
|
L
 0.6%
H
4.6
5.4
|
L
 88.2%
H
2.6
5.4
|
L
 33.4%
H
2.6
5.4
|
L
 -91.9%
H
2.1
125
|
L
 -99.6%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
3,859.5
|
154.4
|
L
 -1.3%
H
154.1
158.3
|
L
 -0.4%
H
150.9
162.2
|
L
 10.4%
H
135.1
162.2
|
L
 22.9%
H
113.4
162.2
|
L
 12.5%
H
107
162.2
|
L
 -12.4%
H
78.4
196.3
|
L
 -25.5%
H
78.4
282
|
L
 34.3%
H
78.4
321.7
|
| Idexx Laboratories |
|
44,456.1
|
563.6
|
L
 0.9%
H
559.7
573.0
|
L
 1.0%
H
547.4
577.2
|
L
 1.2%
H
518.6
577.2
|
L
 0.1%
H
518.6
594.5
|
L
 4.2%
H
506.9
770.0
|
L
 8.1%
H
356.3
770.0
|
L
 -15.5%
H
317.1
770.0
|
L
 493.5%
H
92.5
770.0
|
| QTREX Quantum |
|
89.7
|
1.6
|
L
 0.6%
H
1.5
1.6
|
L
 12.6%
H
1.5
1.8
|
L
 13.4%
H
1.3
2.6
|
L
 283.3%
H
0.3
3.9
|
L
 17.5%
H
0.3
3.9
|
L
 14.2%
H
0.3
3.9
|
L
H
0.3
9.6
|
L
H
0.3
9.6
|
| Intercure Ltd |
|
55.4
|
1.0
|
L
 -1.0%
H
1.0
1.0
|
L
 -11.0%
H
1.0
1.1
|
L
 14.1%
H
0.9
1.2
|
L
 27.6%
H
0.7
1.2
|
L
 -39.4%
H
0.7
1.8
|
L
 -42.6%
H
0.7
3.7
|
L
 -84.2%
H
0.7
8.8
|
L
H
0.7
19.4
|
| Inogen Inc |
|
177.1
|
6.5
|
L
 0.2%
H
6.4
6.6
|
L
 -0.9%
H
6.3
6.8
|
L
 -0.8%
H
6.3
7.1
|
L
 3.3%
H
5.9
7.7
|
L
 -10.5%
H
5.3
9.1
|
L
 -36.4%
H
4.1
13.3
|
L
 -90.6%
H
4.1
82.4
|
L
 -87.4%
H
4.1
287.8
|
| Inmode Ltd |
|
878.3
|
15.3
|
L
 1.8%
H
14.9
15.4
|
L
 3.2%
H
14.4
15.4
|
L
 13.4%
H
13.2
15.4
|
L
 12.9%
H
13.2
15.4
|
L
 0.7%
H
12.7
16.7
|
L
 -61.6%
H
12.7
48.3
|
L
 -68.2%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.0
|
1.1
|
L
 -2.6%
H
1.1
1.2
|
L
 -30.3%
H
1.1
1.6
|
L
 -19.9%
H
1.1
3.1
|
L
 -43.8%
H
1.1
3.1
|
L
 -98.9%
H
1.1
169.6
|
L
 -100.0%
H
1.1
10367.9
|
L
 -100.0%
H
1.1
131328
|
L
 -100.0%
H
1.1
709632
|
| IRIDEX Corp |
|
19.1
|
1.1
|
L
 -1.8%
H
1.1
1.1
|
L
 -2.7%
H
1.1
1.2
|
L
 -2.7%
H
1.1
1.2
|
L
 10%
H
1.0
1.2
|
L
 6.8%
H
0.9
1.7
|
L
 -46.3%
H
0.8
3.7
|
L
 -83.4%
H
0.8
9.5
|
L
 -93.1%
H
0.8
16.5
|
| Iradimed Corp |
|
1,242.5
|
97.2
|
L
 -0.9%
H
97.1
98.6
|
L
 -3.7%
H
95.1
103.0
|
L
 1.3%
H
89.7
103.0
|
L
 4.1%
H
77.0
103.0
|
L
 63.4%
H
55.1
107.9
|
L
 104.8%
H
36.1
107.9
|
L
 218.2%
H
26
107.9
|
L
 339.2%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,816.3
|
116.1
|
L
 -1.5%
H
114.5
118.1
|
L
 -8.2%
H
114.5
129.9
|
L
 1.9%
H
100.9
129.9
|
L
 0.8%
H
100.9
130.0
|
L
 -13.8%
H
100.9
212
|
L
 11.9%
H
55.9
212
|
L
 88.0%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
144,066.4
|
406.8
|
L
 -1.2%
H
403.3
415.9
|
L
 -4.5%
H
403.3
443.8
|
L
 -1.3%
H
397.5
443.8
|
L
 -9.7%
H
396.7
491.2
|
L
 -22.7%
H
396.7
603.9
|
L
 19.5%
H
254.9
616
|
L
 28.4%
H
180.1
616
|
L
 439.3%
H
67.9
616
|
| Jowell Global Ltd |
|
4.8
|
2
|
L
 2.6%
H
2
2
|
L
 -2.4%
H
2.0
2.1
|
L
 -17.0%
H
2.0
2.7
|
L
 -17.7%
H
2.0
3
|
L
 -20%
H
1.5
3
|
L
 -39.2%
H
1
5.6
|
L
 -97.8%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
105.0
|
36.6
|
L
 2.5%
H
36.5
37.0
|
L
 -0.2%
H
35.7
38.0
|
L
 1.7%
H
33.3
38.1
|
L
 4.8%
H
33.3
41.2
|
L
 -37.4%
H
33.3
60.9
|
L
 146.8%
H
14.6
71.3
|
L
 178.3%
H
12.1
71.3
|
L
 93.0%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
522.2
|
20.3
|
L
 0.5%
H
19.9
20.5
|
L
 1.9%
H
19.4
21.4
|
L
 10.1%
H
17.6
21.4
|
L
 27.3%
H
14.4
21.4
|
L
 -9.4%
H
14.4
23.7
|
L
 -52.6%
H
14.4
46.0
|
L
 -66.6%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
196.6
|
4.3
|
L
 -3.4%
H
4.2
4.5
|
L
 -4.7%
H
4.2
4.7
|
L
 7.5%
H
3.8
4.7
|
L
 1.7%
H
3.8
4.7
|
L
 14.8%
H
2.9
6.6
|
L
 32.1%
H
1.9
6.6
|
L
 19.9%
H
1.8
6.6
|
L
 851.1%
H
0.3
12.8
|
| Standard BioTools Inc |
|
360.1
|
0.9
|
L
 -2.1%
H
0.9
1.0
|
L
 1.1%
H
0.8
1.0
|
L
 4.6%
H
0.7
1.0
|
L
 4.6%
H
0.7
1.3
|
L
 -31.9%
H
0.7
1.7
|
L
 -58.6%
H
0.7
3.2
|
L
 -84.6%
H
0.7
7.5
|
L
 -90.5%
H
0.7
14.9
|
| LivaNova PLC |
|
4,535.3
|
82.6
|
L
 0.1%
H
81.5
82.8
|
L
 -1.3%
H
81.5
85.3
|
L
 5.3%
H
77.5
85.3
|
L
 31.5%
H
56.4
85.3
|
L
 76.9%
H
41.0
85.3
|
L
 59.2%
H
32.5
85.3
|
L
 2.0%
H
32.5
93.9
|
L
 62.1%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
2,347.7
|
102.7
|
L
 0.3%
H
101.0
103.4
|
L
 -0.1%
H
99.5
106.1
|
L
 11.3%
H
88.6
106.1
|
L
 -10.4%
H
88.6
118.0
|
L
 19.8%
H
79
118.0
|
L
 60.4%
H
44.3
118.0
|
L
 71.6%
H
38.3
118.0
|
L
 649.9%
H
13.6
118.0
|
| LENSAR Inc |
|
73.8
|
6.0
|
L
 1.4%
H
6.0
6.1
|
L
 -6.1%
H
5.9
6.4
|
L
 5.8%
H
5.6
6.5
|
L
 5.4%
H
5.1
6.5
|
L
 -54.2%
H
5.1
13.4
|
L
 50.6%
H
1.8
17.3
|
L
 -26.5%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,877.8
|
105.6
|
L
 -0.3%
H
104.6
107.0
|
L
 -3.9%
H
99.6
110.6
|
L
 5.4%
H
99.6
111.9
|
L
 31.1%
H
79.6
111.9
|
L
 26.0%
H
47.3
111.9
|
L
 24.5%
H
47.3
126.9
|
L
 289.7%
H
22.2
126.9
|
L
 2171.8%
H
3.5
126.9
|
| Lucid Diagnostics Inc |
|
190.8
|
1
|
L
 1.0%
H
1.0
1.0
|
L
 -6.5%
H
1.0
1.1
|
L
 -1.0%
H
1.0
1.1
|
L
 -13.0%
H
0.9
1.4
|
L
 -15.3%
H
0.9
1.6
|
L
 -28.1%
H
0.6
1.8
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
65.0
|
1.5
|
L
 4.8%
H
1.4
1.6
|
L
 10.8%
H
1.4
1.6
|
L
 7.7%
H
1.2
1.6
|
L
 12.4%
H
1.2
1.7
|
L
 -41.9%
H
1.1
3.9
|
L
 -88.1%
H
1.1
14.8
|
L
 -96.2%
H
1.1
45.5
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
332.3
|
8.1
|
L
 -0.4%
H
8.0
8.2
|
L
 -6.8%
H
7.7
8.9
|
L
 1.1%
H
7.7
9.3
|
L
 13.5%
H
6.4
9.3
|
L
 12.2%
H
5.0
9.3
|
L
 7.1%
H
1.8
12.5
|
L
 -77.0%
H
1.8
39.8
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
612.2
|
4.1
|
L
 -0.7%
H
4.1
4.2
|
L
 4.1%
H
3.9
4.3
|
L
 12.9%
H
3.6
4.3
|
L
 6.2%
H
3.0
4.3
|
L
 -39.4%
H
3.0
8.0
|
L
 -37.8%
H
3.0
10.1
|
L
 -64.3%
H
2.4
16.0
|
L
 -50.2%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
528.2
|
95.6
|
L
 0.2%
H
93.9
96.4
|
L
 -9.4%
H
90
106.0
|
L
 -10.8%
H
87.2
110.1
|
L
 -0.2%
H
81.3
114.0
|
L
 5.9%
H
55.5
114.0
|
L
 -22.4%
H
55.5
155.1
|
L
 -65.7%
H
55.5
333.4
|
L
 -24.0%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
4,381.1
|
73.4
|
L
 2.8%
H
70.5
73.5
|
L
 3.3%
H
70
73.5
|
L
 9.6%
H
64.5
73.5
|
L
 7.6%
H
59.7
73.5
|
L
 -22.8%
H
59.7
94.8
|
L
 -9.9%
H
59.7
111.5
|
L
 15.8%
H
50.5
111.5
|
L
 251.6%
H
19.5
111.5
|
| Modular Medical Inc |
|
21.6
|
4.0
|
L
 -1.7%
H
3.9
4.1
|
L
 -13.3%
H
3.9
4.8
|
L
 -14.6%
H
3.9
6
|
L
 -18.7%
H
3.1
6
|
L
 -82.2%
H
3.1
30
|
L
 -86.1%
H
3.1
79.5
|
L
 -99.2%
H
3.1
540
|
L
 -83.6%
H
3.1
585.0
|
| Myriad Genetics Inc |
|
550.6
|
5.8
|
L
 -4.4%
H
5.7
6.1
|
L
 -2.7%
H
5.7
6.3
|
L
 31.6%
H
4.2
6.3
|
L
 34.0%
H
3.5
6.3
|
L
 6%
H
3.5
8.6
|
L
 -74.5%
H
3.5
29.3
|
L
 -82.4%
H
3.5
37.0
|
L
 -81.6%
H
3.5
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.5
|
L
 -2.0%
H
0.5
0.5
|
L
H
0.5
0.5
|
L
 -12.7%
H
0.4
0.6
|
L
 -76.5%
H
0.4
2.4
|
L
 -78.0%
H
0.4
5.3
|
L
 -86.9%
H
0.4
5.3
|
L
H
0.4
13.2
|
L
H
0.4
13.2
|
| ENvue Medical Inc |
|
3.2
|
0.5
|
L
 -1.9%
H
0.5
0.5
|
L
 1.9%
H
0.4
0.5
|
L
 -37.7%
H
0.4
0.9
|
L
 -68.1%
H
0.4
1.8
|
L
 -94.5%
H
0.4
17.4
|
L
 -99.9%
H
0.4
465.3
|
L
 -100.0%
H
0.4
9218
|
L
 -100.0%
H
0.4
18700
|
| ENDRA Life Sciences Inc |
|
7.1
|
5.6
|
L
 2.2%
H
5.4
6.3
|
L
 18.9%
H
4.5
6.3
|
L
 33.9%
H
3.6
6.7
|
L
 13.6%
H
3.6
6.7
|
L
 -29.9%
H
3.0
9.9
|
L
 -92.2%
H
0.0
139.5
|
L
 -99.7%
H
0.0
2090
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,094.0
|
9.6
|
L
 -1.3%
H
9.5
9.8
|
L
 3%
H
9.1
9.8
|
L
 4.9%
H
8.7
9.8
|
L
 2.1%
H
8.2
9.9
|
L
 72.4%
H
4.6
11.4
|
L
 -55.3%
H
3.9
24.1
|
L
 -78.6%
H
3.9
47.8
|
L
 -56.2%
H
3.9
48.9
|
| Nephros Inc |
|
39.4
|
3.6
|
L
 3.7%
H
3.4
3.6
|
L
 6.8%
H
3.3
3.7
|
L
 13.4%
H
3.1
3.8
|
L
 22.6%
H
2.7
3.8
|
L
 -3.2%
H
2.7
6.4
|
L
 152.1%
H
1.3
6.4
|
L
 -60.0%
H
0.9
9.7
|
L
 52.5%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
25.1
|
2.9
|
L
 4.7%
H
2.6
2.9
|
L
 -4%
H
2.6
3.2
|
L
 -13.3%
H
2.6
3.5
|
L
 -34.4%
H
2.6
5.4
|
L
 -36%
H
2.6
7.0
|
L
 -67.1%
H
2.4
12
|
L
 -92.0%
H
2.4
40.8
|
L
H
2.4
180
|
| Nano X Imaging Ltd |
|
73.1
|
1.1
|
L
 -10.3%
H
1.1
1.2
|
L
 -19.2%
H
1.1
1.4
|
L
 -35.2%
H
0.7
1.9
|
L
 -53.7%
H
0.7
3.1
|
L
 -79.7%
H
0.7
5.7
|
L
 -92.9%
H
0.7
16.5
|
L
 -96.6%
H
0.7
32.4
|
L
H
0.7
94.8
|
| NeuroPace Inc |
|
583.3
|
17.1
|
L
 0.8%
H
16.5
17.4
|
L
 6.0%
H
16.2
18.2
|
L
 8.9%
H
14.9
18.2
|
L
 20.0%
H
13.7
19.6
|
L
 68.2%
H
7.6
19.6
|
L
 303.5%
H
3.9
19.6
|
L
 -20.4%
H
1.2
25.3
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
33.7
|
0.7
|
L
 1.4%
H
0.7
0.7
|
L
 2.9%
H
0.7
0.7
|
L
 -7.7%
H
0.6
0.9
|
L
 -44.2%
H
0.6
1.4
|
L
 -70.4%
H
0.6
2.9
|
L
 -68.1%
H
0.6
3.9
|
L
 -85.0%
H
0.6
6.8
|
L
 -100.0%
H
0.6
161503.1
|
| Nortech Systems Inc |
|
38.8
|
13.9
|
L
 -4.4%
H
13.9
15.0
|
L
 -4.6%
H
13.4
15.7
|
L
 -18.5%
H
13.4
17.6
|
L
 0.7%
H
11.2
18.0
|
L
 53.2%
H
6.5
18.0
|
L
 40.8%
H
6.5
19.2
|
L
 55.8%
H
6.5
19.6
|
L
 270.1%
H
2.5
19.6
|
| Natera Inc |
|
38,661.0
|
270.0
|
L
 -4.2%
H
269.0
283.9
|
L
 -3.4%
H
269.0
288.0
|
L
 24.7%
H
208.8
288.0
|
L
 39.9%
H
184.8
288.0
|
L
 65.3%
H
131.8
288.0
|
L
 458.8%
H
36.9
288.0
|
L
 123.2%
H
26.1
288.0
|
L
 2056.2%
H
7.4
288.0
|
| Nutriband Inc |
|
36.0
|
3.0
|
L
 -4.2%
H
3.0
3.1
|
L
 -3.3%
H
3.0
3.3
|
L
 -13.2%
H
2.9
3.5
|
L
 -24.1%
H
2.9
4.3
|
L
 -63.9%
H
2.9
9.2
|
L
 -4.8%
H
1.5
11.8
|
L
 -70.0%
H
1.5
12.9
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
0.3
|
3.0
|
L
 5.6%
H
2.9
3.2
|
L
 -3.5%
H
2.8
3.5
|
L
 1926.7%
H
0.1
3.8
|
L
 181.5%
H
0.1
3.8
|
L
 -59.1%
H
0.1
26.0
|
L
 -99.9%
H
0.1
4130.7
|
L
 -100.0%
H
0.1
779100
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
1,887.9
|
16.3
|
L
 -5.7%
H
16.0
17.4
|
L
 -5.2%
H
16.0
18.1
|
L
 -2.1%
H
13.4
18.4
|
L
 54.1%
H
10.4
18.9
|
L
 -11.7%
H
9.8
18.9
|
L
 -61.1%
H
9.8
42.0
|
L
 -91.6%
H
9.8
195.8
|
L
 39.8%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.6
|
11.4
|
L
 3.3%
H
11.2
11.7
|
L
 2.3%
H
10.5
12.3
|
L
 10.6%
H
9.7
12.3
|
L
 2.8%
H
9.0
13.4
|
L
 -92.5%
H
8.7
196.7
|
L
 -91.5%
H
8.7
244.0
|
L
 -94.9%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
9.9
|
0.5
|
L
 2.2%
H
0.4
0.5
|
L
 27.8%
H
0.4
0.5
|
L
H
0.3
0.5
|
L
 15%
H
0.3
0.6
|
L
 -54%
H
0.3
2
|
L
 -51.6%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
171.1
|
1.7
|
L
 2.4%
H
1.7
1.8
|
L
 -0.6%
H
1.6
1.9
|
L
 30.5%
H
1.3
1.9
|
L
 -40.2%
H
1.3
3.4
|
L
 -77.9%
H
1.3
8.6
|
L
 -77.9%
H
1.3
20
|
L
 -95.2%
H
1.3
37
|
L
H
1.3
37
|
| Nanobiotix (ADR) |
|
2,035.0
|
40.1
|
L
 2.9%
H
39
42.5
|
L
 4.4%
H
37.2
42.9
|
L
 19.4%
H
31.7
42.9
|
L
 32.1%
H
29.9
57.1
|
L
 666.2%
H
4.9
57.1
|
L
 521.2%
H
2.8
57.1
|
L
 176.7%
H
1.8
57.1
|
L
H
1.8
57.1
|
| Orchestra BioMed Holdings Inc |
|
238.9
|
4.0
|
L
 1.8%
H
3.8
4
|
L
 -4.8%
H
3.8
4.3
|
L
 -0.8%
H
3.8
4.8
|
L
 -3.4%
H
3.7
4.8
|
L
 33%
H
2.2
5.4
|
L
 -39.9%
H
2.2
11.7
|
L
 -60.1%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
470.1
|
11.6
|
L
 1.3%
H
11.3
11.7
|
L
 17%
H
10.4
12.0
|
L
 19.5%
H
8.9
12.0
|
L
 -6.1%
H
8.9
13.0
|
L
 2.4%
H
8.9
17.0
|
L
 -36.9%
H
8.9
21.6
|
L
 -71.1%
H
8.9
43.3
|
L
 -75.1%
H
8.9
74.4
|
| Outset Medical Inc |
|
82.1
|
4.4
|
L
 -0.5%
H
4.3
4.5
|
L
 -6.1%
H
4.3
5.2
|
L
 -4.1%
H
4
5.5
|
L
 5.5%
H
3.5
5.5
|
L
 -78.5%
H
3
20.5
|
L
 -98.5%
H
0.5
314.4
|
L
 -99.3%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
308.8
|
2.4
|
L
 -2.4%
H
2.4
2.5
|
L
 1.7%
H
2.3
2.6
|
L
 -2.8%
H
2.3
2.6
|
L
 0.8%
H
2.0
2.8
|
L
 -45.5%
H
2.0
7.1
|
L
 -27.3%
H
2.0
7.1
|
L
 -85.4%
H
1.8
17.5
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
296.0
|
4.3
|
L
 0.5%
H
4.2
4.3
|
L
 -1.2%
H
4.2
4.5
|
L
 6.7%
H
4
4.6
|
L
 45.3%
H
2.9
4.6
|
L
 41.0%
H
2.1
4.6
|
L
 -5.5%
H
2.1
8.5
|
L
 -58.5%
H
2.1
13.6
|
L
 -33.2%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
484.5
|
1.6
|
L
 -3.1%
H
1.5
1.6
|
L
 -7.1%
H
1.5
1.7
|
L
 13.9%
H
1.3
1.8
|
L
 16.4%
H
1.1
1.8
|
L
 4%
H
1.1
2.7
|
L
 -88.4%
H
0.9
14.6
|
L
 -95.1%
H
0.9
35.6
|
L
 -79.3%
H
0.9
53.7
|
| PAVmed Inc |
|
40.1
|
5.6
|
L
 0.9%
H
5.5
5.7
|
L
 -1.9%
H
5.1
5.8
|
L
 12.5%
H
3.9
6.5
|
L
 -39.4%
H
3.9
9.7
|
L
 -68.9%
H
3.9
28.4
|
L
 -96.8%
H
3.9
270
|
L
 -99.8%
H
3.9
4365
|
L
H
3.9
6858
|
| Pro-Dex Inc (co) |
|
200.8
|
62.9
|
L
 1.4%
H
60.7
63.5
|
L
 2.5%
H
57.1
63.5
|
L
 1.5%
H
55.3
67.8
|
L
 22.2%
H
43.3
69.0
|
L
 31.7%
H
23.5
69.0
|
L
 237.4%
H
14.5
70.3
|
L
 107.5%
H
12.4
70.3
|
L
 1058.2%
H
3.8
70.3
|
| Pulse Biosciences Inc |
|
1,819.5
|
26.3
|
L
 -3.5%
H
25.9
27.2
|
L
 -10.0%
H
25.9
29.9
|
L
 5.2%
H
24.3
31
|
L
 40.8%
H
18.2
31
|
L
 53.6%
H
12.6
31
|
L
 257.7%
H
3.8
31
|
L
 42.6%
H
1.2
31
|
L
 484.2%
H
1.2
45.8
|
| Axe Compute Inc |
|
83.8
|
7.4
|
L
 5.6%
H
6.6
7.6
|
L
 4.0%
H
6.6
8.9
|
L
 11.2%
H
5.9
8.9
|
L
 84.9%
H
3.1
10.9
|
L
 -38.7%
H
1.0
32.1
|
L
 -90.5%
H
1.0
106.8
|
L
 -97.9%
H
1.0
439.8
|
L
 -99.9%
H
1.0
20250
|
| Precision Optics Corp Inc |
|
54.5
|
5.0
|
L
 0.6%
H
4.8
5.0
|
L
 -1.6%
H
4.7
5.1
|
L
 -11.9%
H
4.7
6.2
|
L
 19.4%
H
4.0
6.2
|
L
 -0.8%
H
3.6
6.2
|
L
 -15.6%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
11,171.0
|
161.3
|
L
 1.9%
H
158.3
161.8
|
L
 -2.0%
H
152.8
164.4
|
L
 7.0%
H
138.8
167.8
|
L
 -18.1%
H
138.8
206.0
|
L
 -45.8%
H
138.8
354.9
|
L
 -43.5%
H
125.8
354.9
|
L
 -42.5%
H
125.8
354.9
|
L
 402.3%
H
30.7
354.9
|
| Procept BioRobotics Corp |
|
1,189.0
|
20.9
|
L
 5.8%
H
19.6
21
|
L
 -0.7%
H
19.6
21.9
|
L
 -28.2%
H
19.6
28.2
|
L
 -10.0%
H
19.6
29.7
|
L
 -64.7%
H
19.4
62.2
|
L
 -46.2%
H
19.4
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
303.6
|
17.9
|
L
 0.1%
H
16.8
18.5
|
L
 5.5%
H
15.9
18.6
|
L
 -7.2%
H
15.9
22.2
|
L
 0.7%
H
14
22.2
|
L
 128.4%
H
7.2
23.6
|
L
 35.2%
H
2.9
23.6
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
255.8
|
7.0
|
L
 -4.0%
H
6.9
7.5
|
L
 3.4%
H
6.8
7.9
|
L
 4.9%
H
6.3
7.9
|
L
 18.3%
H
5.8
7.9
|
L
 15.8%
H
3.8
9.0
|
L
 -45.0%
H
3.8
13.2
|
L
 -59.9%
H
3.1
18.3
|
L
 -34.3%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
1,245.8
|
18.3
|
L
 4.8%
H
17.2
18.6
|
L
 0.1%
H
15.5
18.8
|
L
 35.3%
H
11.8
19.8
|
L
 31.9%
H
9.9
19.8
|
L
 -42.1%
H
9.9
35.6
|
L
 -78.5%
H
9.9
89.1
|
L
 -85.1%
H
9.9
180.1
|
L
 -6.0%
H
9.9
306.7
|
| Quanterix Corp |
|
182.8
|
3.9
|
L
 -2.5%
H
3.8
4.1
|
L
 -10.4%
H
3.8
4.5
|
L
 26.4%
H
2.8
4.6
|
L
 15.5%
H
2.4
4.6
|
L
 -33.8%
H
2.4
8.8
|
L
 -84.2%
H
2.4
29.7
|
L
 -93.5%
H
2.4
60.9
|
L
H
2.4
92.6
|
| AVITA Medical Inc |
|
125.0
|
4.1
|
L
 -7.9%
H
4.1
4.4
|
L
 -19.8%
H
4.1
5.2
|
L
 -1.5%
H
3.7
5.2
|
L
 -19.0%
H
3.7
5.9
|
L
 -31.7%
H
3.2
7.1
|
L
 -74.4%
H
3.2
21.7
|
L
 -79.5%
H
3.2
21.7
|
L
 -46.2%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
22.1
|
5.6
|
L
 -2.6%
H
5.6
5.9
|
L
 1.3%
H
5.4
6.1
|
L
 -15.9%
H
4.9
7
|
L
 -38.4%
H
4.9
9.4
|
L
 -56.5%
H
4.9
21
|
L
 -90.9%
H
4.9
62.4
|
L
 -93.9%
H
4.9
93.4
|
L
 -99.4%
H
4.9
987.8
|
| Vyome Holdings Inc |
|
15.8
|
2.3
|
L
 0.9%
H
2.2
2.3
|
L
 -2.2%
H
2.1
2.3
|
L
 3.2%
H
2.1
2.4
|
L
 2.7%
H
1.8
2.5
|
L
 -7.8%
H
1.8
12.9
|
L
 -97.4%
H
0.3
96.3
|
L
 -100.0%
H
0.3
16965
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
503.7
|
8.4
|
L
 -0.7%
H
8.2
8.5
|
L
 4.5%
H
7.0
9.6
|
L
 18.5%
H
6.2
9.6
|
L
 27.6%
H
6
9.6
|
L
 1017.3%
H
0.4
9.6
|
L
 44.2%
H
0.4
9.6
|
L
 -25.3%
H
0.4
19.5
|
L
 -99.3%
H
0.4
1373.8
|
| Sanmina Corp |
|
11,190.7
|
208.8
|
L
 -1.9%
H
207.9
212.9
|
L
 -5%
H
199.5
231.4
|
L
 -9.7%
H
199.5
269.5
|
L
 41.3%
H
146.1
288.7
|
L
 100.1%
H
95.5
288.7
|
L
 238.7%
H
43.4
288.7
|
L
 442.3%
H
35.1
288.7
|
L
 657.9%
H
18.3
288.7
|
| Sight Sciences Inc |
|
289.5
|
5.3
|
L
 1.1%
H
5.2
5.4
|
L
 -2.4%
H
5.1
5.6
|
L
 10.4%
H
4.7
5.9
|
L
 54.2%
H
3.4
5.9
|
L
 55.1%
H
3.1
9.2
|
L
 -33.9%
H
1.0
9.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,252.8
|
18.4
|
L
 0.2%
H
18.2
18.6
|
L
 2.7%
H
17.4
18.6
|
L
 13.2%
H
15.4
18.6
|
L
 19.9%
H
14.3
18.6
|
L
 54.9%
H
10.9
19.9
|
L
 2.2%
H
9.5
19.9
|
L
 -23.4%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
778.8
|
17.6
|
L
 0.8%
H
16.9
17.8
|
L
 2.6%
H
16.8
17.9
|
L
 14.3%
H
14.9
17.9
|
L
 36.8%
H
11.5
17.9
|
L
 -6.5%
H
11.5
21.9
|
L
 -33.8%
H
11.5
27.9
|
L
 -37.2%
H
11.1
31.5
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
10.9
|
1.7
|
L
 1.2%
H
1.7
1.7
|
L
 -9.5%
H
1.7
1.9
|
L
 -16.9%
H
1.7
2.2
|
L
 -35.8%
H
1.7
3
|
L
 -50.4%
H
1.7
6.8
|
L
 -99.4%
H
0.1
364
|
L
 -100.0%
H
0.1
40800
|
L
 -100.0%
H
0.1
10080000
|
| Beauty Health Co (Class A) |
|
117.9
|
0.9
|
L
 -3.2%
H
0.9
1.0
|
L
 24.7%
H
0.7
1.2
|
L
 37.9%
H
0.6
1.2
|
L
 1.1%
H
0.6
1.2
|
L
 -55.4%
H
0.6
2.7
|
L
 -89.6%
H
0.6
9.0
|
L
 -95.1%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
218.3
|
23.8
|
L
 -0.3%
H
23.3
24.7
|
L
 -4.1%
H
23.3
26
|
L
 3.6%
H
20.4
26
|
L
 44.1%
H
16.5
26
|
L
 -22.3%
H
16.1
36.0
|
L
 -39.3%
H
16.1
46.4
|
L
 -36.9%
H
16.1
50.2
|
L
 240.3%
H
2
75
|
| Sensus Healthcare Inc |
|
50.2
|
3.1
|
L
 4.5%
H
2.9
3.1
|
L
 -0.7%
H
2.9
3.1
|
L
 8.2%
H
2.7
3.1
|
L
 -32.1%
H
2.7
4.6
|
L
 -33.4%
H
2.7
5.9
|
L
 -13.6%
H
1.8
9.3
|
L
 -21.8%
H
1.8
15.3
|
L
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,382.1
|
27.8
|
L
 -0.8%
H
27.3
28.2
|
L
 -0.1%
H
25.9
28.4
|
L
 -5.4%
H
25.9
31.3
|
L
 5.0%
H
23.6
35.9
|
L
 55.9%
H
15.6
35.9
|
L
 -46.0%
H
13.5
58.8
|
L
 -80.6%
H
13.5
163.1
|
L
 363.4%
H
5.9
163.1
|
| Neuronetics Inc |
|
122.5
|
1.8
|
L
 6.0%
H
1.5
1.8
|
L
 24.8%
H
1.4
1.8
|
L
 41.9%
H
1.2
1.8
|
L
 30.4%
H
1.1
2.5
|
L
 -50.3%
H
0.8
4.9
|
L
 -18.9%
H
0.5
5.9
|
L
 -88.0%
H
0.5
15
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
36.3
|
11.3
|
L
 2.3%
H
11.1
11.3
|
L
 2.4%
H
11.0
11.4
|
L
 -3.5%
H
10.2
11.8
|
L
 16.6%
H
9
11.9
|
L
 479.9%
H
1.9
12.0
|
L
 118.4%
H
1.7
12.0
|
L
 -33.6%
H
1.7
23.4
|
L
 -95.9%
H
1.7
307.5
|
| SkyAI Inc |
|
49.1
|
1.2
|
L
 -1.7%
H
1.1
1.2
|
L
 -5.7%
H
1.1
1.3
|
L
 4.5%
H
0.9
1.4
|
L
 -30.5%
H
0.9
2.1
|
L
 -80.2%
H
0.9
18.2
|
L
 -100.0%
H
0.0
6204
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
672.9
|
29.8
|
L
 -2.8%
H
29.2
30.8
|
L
 -4.9%
H
29.2
32.4
|
L
 14.9%
H
25.2
32.4
|
L
 27.3%
H
20.5
32.4
|
L
 190.7%
H
9.4
37.8
|
L
 22.6%
H
8.6
37.8
|
L
 -40.1%
H
6.3
51
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
38.1
|
0.9
|
L
 -1.2%
H
0.8
0.9
|
L
 18.1%
H
0.7
1
|
L
 -9.6%
H
0.7
1
|
L
 49.1%
H
0.6
1.3
|
L
 -58.9%
H
0.5
2.2
|
L
 -91.5%
H
0.5
10.8
|
L
 -94.5%
H
0.5
16.3
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
1.6
|
0.5
|
L
 2%
H
0.4
0.5
|
L
 2%
H
0.4
0.5
|
L
 -36.3%
H
0.4
0.7
|
L
 -45.2%
H
0.4
1.4
|
L
 -88%
H
0.4
5.6
|
L
 -99.6%
H
0.4
194.8
|
L
H
0.4
11050
|
L
H
0.4
11050
|
| Treace Medical Concepts Inc |
|
280.3
|
4.3
|
L
 -7.3%
H
4.3
4.6
|
L
 2.6%
H
4.1
4.7
|
L
 2.1%
H
3.8
4.8
|
L
 138.7%
H
1.7
4.8
|
L
 -30.4%
H
1.2
7.8
|
L
 -81.4%
H
1.2
25.2
|
L
 -84.8%
H
1.2
31.8
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,461.8
|
71.2
|
L
 -1.3%
H
70.2
73.3
|
L
 3.4%
H
68.5
73.3
|
L
 -4.7%
H
64.8
80.7
|
L
 -37.5%
H
60.1
120.9
|
L
 -42.9%
H
60.1
156
|
L
 -17.6%
H
36.4
177.4
|
L
 106.4%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,056.0
|
15.4
|
L
 0.3%
H
15
15.5
|
L
 0.6%
H
14.8
15.9
|
L
 -5.1%
H
14.0
17.2
|
L
 -19.7%
H
12.3
22.0
|
L
 -4.7%
H
10.0
29.7
|
L
 -38.2%
H
10.0
53.7
|
L
 -84.2%
H
10.0
155.9
|
L
 -80.0%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
7.9
|
0.4
|
L
H
0.4
0.4
|
L
 2.6%
H
0.4
0.4
|
L
 -43.5%
H
0.3
0.7
|
L
 -45.1%
H
0.3
0.8
|
L
 -98.0%
H
0.3
86
|
L
 -99.9%
H
0.3
656.3
|
L
 -100.0%
H
0.3
1906.3
|
L
 -100.0%
H
0.3
8550
|
| Utah Medical Products Inc |
|
216.4
|
68.0
|
L
 -0.6%
H
67.9
70.3
|
L
 -6.6%
H
66.4
74.4
|
L
 -0.9%
H
64.8
75.8
|
L
 3.1%
H
62.5
75.8
|
L
 18.8%
H
53.7
75.8
|
L
 -27.2%
H
51.3
99.5
|
L
 -20.8%
H
51.3
133.9
|
L
 4.4%
H
51.3
133.9
|
| Vivani Medical Inc |
|
117.3
|
1.4
|
L
 -12.8%
H
1.3
1.5
|
L
 7.9%
H
1.3
1.7
|
L
 20.4%
H
1.1
1.7
|
L
 30.8%
H
1.0
1.7
|
L
 7.1%
H
0.9
1.9
|
L
 4.6%
H
0.8
7.8
|
L
 -89.1%
H
0.8
15.8
|
L
 -98.6%
H
0.8
109.2
|
| Veracyte Inc |
|
4,545.8
|
57.0
|
L
 -3.9%
H
56.5
59.1
|
L
 -0.2%
H
54.3
60.0
|
L
 18.3%
H
46.0
60.9
|
L
 83.2%
H
31.2
60.9
|
L
 107.0%
H
22.6
60.9
|
L
 126.0%
H
18.6
60.9
|
L
 50.0%
H
14.9
60.9
|
L
 1041.7%
H
4.8
86.0
|
| Varex Imaging Corp |
|
465.7
|
11.1
|
L
 2.6%
H
10.6
11.2
|
L
 4.2%
H
10.2
11.2
|
L
 4.9%
H
9.6
11.7
|
L
 -1.2%
H
9.1
12.8
|
L
 29.4%
H
6.8
14.6
|
L
 -52.3%
H
6.8
23.6
|
L
 -58.8%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
6.0
|
0.4
|
L
 -8.5%
H
0.4
0.5
|
L
 -4.4%
H
0.4
0.5
|
L
 -32.8%
H
0.4
0.7
|
L
 -64.5%
H
0.4
1.5
|
L
 -93.6%
H
0.4
8.0
|
L
 -96.6%
H
0.4
48.8
|
L
 -99.6%
H
0.4
177.3
|
L
H
0.4
360.3
|
| Wrap Tech Inc |
|
137.1
|
2.5
|
L
 4.2%
H
2.1
2.7
|
L
 74.5%
H
1.5
2.7
|
L
 100%
H
1.0
2.7
|
L
 64%
H
1.0
2.7
|
L
 64%
H
1.0
3.2
|
L
 70.8%
H
1.0
7.0
|
L
 -64.9%
H
1.0
8.5
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
0.3
|
0.4
|
L
 -2.3%
H
0.4
0.4
|
L
 -10.6%
H
0.4
0.5
|
L
 10.5%
H
0.3
0.5
|
L
 -46.8%
H
0.3
0.7
|
L
 -89.2%
H
0.3
4.8
|
L
 -99.5%
H
0.3
84.6
|
L
 -99.7%
H
0.3
328.2
|
L
H
0.3
900
|
| DENTSPLY Sirona Inc |
|
2,456.0
|
12.3
|
L
 3.1%
H
11.8
12.4
|
L
 5.2%
H
11.4
12.5
|
L
 22.1%
H
9.8
12.5
|
L
 4.7%
H
9.4
13.0
|
L
 -26.2%
H
9.4
17.1
|
L
 -69.0%
H
9.4
41.6
|
L
 -80.4%
H
9.4
67.0
|
L
 -80.7%
H
9.4
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
7.2
|
2.9
|
L
 0.7%
H
2.6
2.9
|
L
 7.8%
H
2.5
3.4
|
L
 25.4%
H
2.1
3.4
|
L
 22.8%
H
2.0
4.9
|
L
 -88.0%
H
2.0
41.1
|
L
 -81.6%
H
2.0
79.8
|
L
 -95.0%
H
2.0
107.0
|
L
 -96.5%
H
2.0
125.6
|
| 111 Inc (ADR) |
|
36.9
|
4.2
|
L
 4.7%
H
4
4.2
|
L
 1.7%
H
3.5
4.4
|
L
 -3.7%
H
3.5
5.1
|
L
 -36.2%
H
3.5
7.3
|
L
 -44.2%
H
2.5
11.2
|
L
 52.2%
H
0.4
11.3
|
L
 -46.6%
H
0.4
11.3
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
14.6
|
1.9
|
L
 3.3%
H
1.8
1.9
|
L
 -4.6%
H
1.8
2.0
|
L
 -20.8%
H
1.8
2.9
|
L
 -19.1%
H
1.8
4.5
|
L
 -84.6%
H
1.6
17.2
|
L
 -83.2%
H
1.6
509.9
|
L
H
1.6
509.9
|
L
H
1.6
509.9
|
| HeartBeam Inc |
|
33.3
|
0.6
|
L
 -6.3%
H
0.6
0.6
|
L
 -16.7%
H
0.6
0.7
|
L
 -21.1%
H
0.6
0.8
|
L
 -47.8%
H
0.6
1.3
|
L
 -52.8%
H
0.5
4
|
L
 -62.0%
H
0.5
4
|
L
 -62.0%
H
0.5
4
|
L
 -62.0%
H
0.5
4
|
| Cencora |
|
59,037.6
|
303.4
|
L
 0.3%
H
300.8
304.8
|
L
 2.3%
H
292.5
310.5
|
L
 7.9%
H
269.3
310.5
|
L
 -5.4%
H
244.8
328.0
|
L
 2.1%
H
244.8
377.5
|
L
 57.4%
H
171.7
377.5
|
L
 163.6%
H
111.3
377.5
|
L
 270.4%
H
68.4
377.5
|
| Incannex Healthcare Ltd (ADR) |
|
40.6
|
3.4
|
L
 0.6%
H
3.3
3.5
|
L
 -14.6%
H
3.3
4.0
|
L
 -13.3%
H
3.1
4.2
|
L
 8.7%
H
2.8
5
|
L
 -49.8%
H
2.5
49.8
|
L
 -97.9%
H
2.4
160.2
|
L
 -97.9%
H
2.4
160.2
|
L
 -97.9%
H
2.4
160.2
|
| Rewalk Robotics Ltd |
|
23.6
|
8.4
|
L
 -0.7%
H
8.2
8.5
|
L
 4.5%
H
7.0
9.6
|
L
 18.5%
H
6.2
9.6
|
L
 27.6%
H
6
9.6
|
L
 -7.0%
H
4.1
10.6
|
L
 -88.0%
H
4.1
109.2
|
L
 -93.8%
H
4.1
233.5
|
L
 -99.9%
H
4.1
16485
|
| Work Medical Tech Grp Ltd |
|
5.6
|
2.3
|
L
 13.9%
H
2.1
2.6
|
L
 4.1%
H
1.9
2.6
|
L
 -77%
H
1.8
12
|
L
 -98.2%
H
1.8
733
|
L
 -100%
H
1.8
930000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
| iTonic Holdings Ordinary |
|
5.6
|
0.3
|
L
 3.1%
H
0.3
0.3
|
L
 10%
H
0.3
0.3
|
L
 -23.3%
H
0.3
0.5
|
L
 17.9%
H
0.3
1.2
|
L
 -98.4%
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
| Ceribell Inc |
|
742.2
|
19.6
|
L
 -0.4%
H
19.4
19.8
|
L
 0.1%
H
19.0
20.3
|
L
 6.4%
H
17.1
20.8
|
L
 7.8%
H
15.8
21.7
|
L
 16.7%
H
10.9
24.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
951.0
|
9.8
|
L
 3.0%
H
9.3
9.8
|
L
 -4.6%
H
9.3
11.1
|
L
 2.8%
H
9.1
11.1
|
L
 72.0%
H
5.4
11.1
|
L
 194.3%
H
2.9
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
| Beta Bionics Inc |
|
758.9
|
17.0
|
L
 3.7%
H
15.9
17.1
|
L
 1.6%
H
15.7
17.6
|
L
 24.1%
H
13.0
17.6
|
L
 92.2%
H
8.9
17.6
|
L
 25.6%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| Wellgistics Health Inc |
|
7.7
|
3.1
|
L
 4.1%
H
2.9
3.1
|
L
 3.0%
H
2.8
3.3
|
L
 -17.9%
H
2.8
3.9
|
L
 -48.8%
H
2.8
11.6
|
L
 -93.9%
H
2.8
94.5
|
L
H
2.8
352
|
L
H
2.8
352
|
L
H
2.8
352
|
| Kestra Medical Tech Ltd |
|
1,517.1
|
26.0
|
L
 -2.6%
H
25.3
26.6
|
L
 -3.7%
H
25.3
28.8
|
L
 33.7%
H
18.5
28.8
|
L
 45.4%
H
17.3
28.8
|
L
 71.1%
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
100.4
|
11.7
|
L
 -3.5%
H
11.1
12.3
|
L
 9.9%
H
10.0
12.3
|
L
 -18.8%
H
7.5
15.4
|
L
 -30.6%
H
7.5
21.2
|
L
 -67.5%
H
7.5
46.6
|
L
 -63.9%
H
7.5
46.6
|
L
 -63.9%
H
7.5
46.6
|
L
 -63.9%
H
7.5
46.6
|
| SS Innovations Intl Inc |
|
758.5
|
3.8
|
L
 0.3%
H
3.6
3.9
|
L
 0.3%
H
3.5
3.9
|
L
 7.7%
H
3.2
4.2
|
L
 -11.9%
H
3.2
5.1
|
L
 -29.3%
H
3.1
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
34,703.7
|
41.0
|
L
 0.5%
H
40.2
41.1
|
L
 -5.0%
H
40.0
43.6
|
L
 12.3%
H
34.6
43.6
|
L
 -10%
H
32.8
49.1
|
L
 0.1%
H
32.8
50.9
|
L
 0.1%
H
32.8
50.9
|
L
 0.1%
H
32.8
50.9
|
L
 0.1%
H
32.8
50.9
|
| FocalTherics ADR |
|
-
|
5.4
|
L
 -0.7%
H
5.4
5.5
|
L
 5.0%
H
5.2
5.6
|
L
 16.7%
H
4.7
5.6
|
L
 19.3%
H
4.5
5.6
|
L
 19.3%
H
4.5
5.6
|
L
 19.3%
H
4.5
5.6
|
L
 19.3%
H
4.5
5.6
|
L
 19.3%
H
4.5
5.6
|